Literature DB >> 12406128

Venlafaxine open-label treatment of patients with obsessive-compulsive disorder.

Levent Sevincok, Bulent Uygur.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12406128     DOI： 10.1046/j.1440-1614.2002.t01-5-01101c.x

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN： 0004-8674            Impact factor:   5.744


× No keyword cloud information.
  3 in total

1.  SNRIs pharmacological alternatives for the treatment of obsessive compulsive disorder?

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Innov Clin Neurosci       Date:  2011-06

2.  Venlafaxine augmentation with agomelatine in a patient with obsessive-compulsive disorder and suicidal behaviors.

Authors:  Maria S Signorelli; Carmen Concerto; Eliana Battaglia; Maria C Costanzo; Fortunato Battaglia; Eugenio Aguglia
Journal:  SAGE Open Med Case Rep       Date:  2014-12-04

Review 3.  Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD).

Authors:  Antonio Del Casale; Serena Sorice; Alessio Padovano; Maurizio Simmaco; Stefano Ferracuti; Dorian A Lamis; Chiara Rapinesi; Gabriele Sani; Paolo Girardi; Georgios D Kotzalidis; Maurizio Pompili
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.